Catalyst and Auxiliary
ISOPRINOSINE Typical Properties
| Item | Specification | |
| APPEARANCE | White or almost white crystalline powder ; odorless | |
| Acidity | 6.0-7.0 | |
| Water | NMT 0.5% | |
| Residue on ignition | NMT 0.1% | |
| Heavy metals | NMT 10ppm | |
| Pb | NMT 10ppm | |
| Related substances | P-Aminobenzoic zcid | NMT 0.1% |
| Other single impurity | NMT 0.05% | |
| Total impurities | NMT 0.5% | |
| P-nitrobenzoic acid | NMT 0.0072% | – |
| Ethanol | NMT 0.5% | |
| Ethyl acetate | NMT 0.5% | |
| Residue
solvents |
Benzene | NMT 0.0002% |
| Propylene oxide | NMT 0.0018% | |
| Assay | Inosine(C10H12N4O5):
23.0%~26.0% |
Should be 23.0%~26.0% |
| Dimethylaminoisopropanol-acetamidobenzoate | Should be 74.0%~78.0% | |
ISOPRINOSINE Usage
This product has the effect of anti-virus and enhancing the body’s immunity.
Clinically used for influenza, herpes, measles, chickenpox, mumps, hepatitis,
And for multiple angular cheilitis, focal genital inflammation.
ISOPRINOSINE Package
25kg Paper barrel
ISOPRINOSINE Storage
Store in a cool, dry place. Do not store in direct sunlight.
Isoprinosine Precautions
1. Because the inosine part of the drug is finally converted into uric acid, it can temporarily increase uric acid in serum and urine. Pay attention to drinking plenty of water.
2. Cellular immune function inspection should be performed before medication.